InsiderTrades

Form 4 for PFE Pfizer

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003665 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-01 2022-02-26 PFE JOHNSON RADY A EVP F - Tax $49.61 -21.2K 75.0K -22% -$1.05M
D 2022-03-01 2022-02-26 PFE JOHNSON RADY A EVP M - OptEx $25.60 +29.3K 96.2K +44% +$750.5K
D 2022-03-01 2022-02-26 PFE JOHNSON RADY A EVP M - OptEx $0.00 -29.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-26 F D 7,511 $47.72 88,686 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022.
2 Common Common Stock 2022-02-26 F D 13,688 $50.64 74,998 D — — (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
3 Common Common Stock 2022-02-26 M A 29,317 $25.60 96,197 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
4 Derivative Stock Appreciation Rights 2022-02-26 M D 29,317 $0.00 0 D $25.60 · 2022-02-26 to 2022-02-26 29,317 Common Stock